1: Castro PA, Ramirez A, Sepúlveda FJ, Peters C, Fierro H, Waldron J, Luza S, Fuentealba J, Muñoz FJ, De Ferrari GV, Bush AI, Aguayo LG, Opazo CM. Copper-uptake is critical for the down regulation of synapsin and dynamin induced by neocuproine: modulation of synaptic activity in hippocampal neurons. Front Aging Neurosci. 2014 Dec 3;6:319. doi: 10.3389/fnagi.2014.00319. eCollection 2014. PubMed PMID: 25520655; PubMed Central PMCID: PMC4253966.
2: Patel OV, Wilson WB, Qin Z. Production of LPS-induced inflammatory mediators in murine peritoneal macrophages: neocuproine as a broad inhibitor and ATP7A as a selective regulator. Biometals. 2013 Jun;26(3):415-25. doi: 10.1007/s10534-013-9624-4. Epub 2013 Apr 19. PubMed PMID: 23604539.
3: Kumcu EK, Büyüknacar HS, Göçmen C, Evrüke IC, Onder S. Differential effect of neocuproine, a copper(I) chelator, on contractile activity in isolated ovariectomized non-pregnant rat, pregnant rat and pregnant human uterus. Eur J Pharmacol. 2009 Mar 1;605(1-3):158-63. doi: 10.1016/j.ejphar.2009.01.008. PubMed PMID: 19248249.
4: Soares SAR, Costa SSL, Araujo RGO, Teixeira LSG, Dantas AF. Comparison of Spectrophotometric Methods for the Determination of Copper in Sugar Cane Spirit. J AOAC Int. 2018 May 1;101(3):876-882. doi: 10.5740/jaoacint.17-0154. Epub 2017 Sep 15. PubMed PMID: 28911344.
5: Ho WC, Chung K, Ingram AJ, Waymouth RM. Pd-Catalyzed Aerobic Oxidation Reactions: Strategies To Increase Catalyst Lifetimes. J Am Chem Soc. 2018 Jan 17;140(2):748-757. doi: 10.1021/jacs.7b11372. Epub 2018 Jan 5. PubMed PMID: 29244945.
6: Zhu BZ, Chevion M. Copper-mediated toxicity of 2,4,5-trichlorophenol: biphasic effect of the copper(I)-specific chelator neocuproine. Arch Biochem Biophys. 2000 Aug 15;380(2):267-73. PubMed PMID: 10933881.
7: Paul BD, Snyder SH. Protein sulfhydration. Methods Enzymol. 2015;555:79-90. doi: 10.1016/bs.mie.2014.11.021. Epub 2015 Jan 14. PubMed PMID: 25747476.
8: Roohparvar R, Shamspur T, Mostafavi A. Application of silica coated magnetite nanoparticles modified with Cu(I)-neocuproine as nanosorbent to simultaneous separation-preconcentration of trace amounts of nitrate and nitrite. Nitric Oxide. 2018 Feb 28;73:9-14. doi: 10.1016/j.niox.2017.12.003. Epub 2017 Dec 14. PubMed PMID: 29248688.
9: Tütem E, Apak R, Günaydı E, Sözgen K. Spectrophotometric determination of vitamin E (alpha-tocopherol) using copper(II)-neocuproine reagent. Talanta. 1997 Feb;44(2):249-55. PubMed PMID: 18966741.
10: Arnal N, de Alaniz MJ, Marra CA. Carnosine and neocuproine as neutralizing agents for copper overload-induced damages in cultured human cells. Chem Biol Interact. 2011 Jul 15;192(3):257-63. doi: 10.1016/j.cbi.2011.03.017. Epub 2011 Apr 8. PubMed PMID: 21501601.
11: Nandal P, Khatkar SP, Kumar R, Khatkar A, Taxak VB. Synthesis, Optical Investigation and Biological Properties of Europium(III) Complexes with 2-(4-Chlorophenyl)-1-(2-Hydroxy-4-Methoxyphenyl)Ethan-1-one and Ancillary Ligands. J Fluoresc. 2017 Jan;27(1):1-11. doi: 10.1007/s10895-016-1930-0. Epub 2016 Sep 19. PubMed PMID: 27646650.
12: Al-Sa'doni HH, Megson IL, Bisland S, Butler AR, Flitney FW. Neocuproine, a selective Cu(I) chelator, and the relaxation of rat vascular smooth muscle by S-nitrosothiols. Br J Pharmacol. 1997 Jul;121(6):1047-50. PubMed PMID: 9249237; PubMed Central PMCID: PMC1564784.
13: De Man JG, Moreels TG, De Winter BY, Herman AG, Pelckmans PA. Neocuproine potentiates the activity of the nitrergic neurotransmitter but inhibits that of S-nitrosothiols. Eur J Pharmacol. 1999 Sep 24;381(2-3):151-9. PubMed PMID: 10554883.
14: Göçmen C, Göktürk HS, Ertuğ PU, Onder S, Dikmen A, Baysal F. Effect of neocuproine, a selective Cu(I) chelator, on nitrergic relaxations in the mouse corpus cavernosum. Eur J Pharmacol. 2000 Oct 13;406(2):293-300. PubMed PMID: 11020493.
15: Starosta R, Bykowska A, Kyzioł A, Płotek M, Florek M, Król J, Jeżowska-Bojczuk M. Copper(I) (pseudo)halide complexes with neocuproine and aminomethylphosphines derived from morpholine and thiomorpholine - in vitro cytotoxic and antimicrobial activity and the interactions with DNA and serum albumins. Chem Biol Drug Des. 2013 Nov;82(5):579-86. doi: 10.1111/cbdd.12187. Epub 2013 Aug 10. PubMed PMID: 23841542.
16: Vanin AF, Serezhenkov VA, Malenkova IV. Nitric oxide initiates iron binding to neocuproine. Nitric Oxide. 2001 Apr;5(2):166-75. PubMed PMID: 11292366.
17: Apak R, Güçlü K, Ozyürek M, Karademir SE, Altun M. Total antioxidant capacity assay of human serum using copper(II)-neocuproine as chromogenic oxidant: the CUPRAC method. Free Radic Res. 2005 Sep;39(9):949-61. PubMed PMID: 16087476.
18: Byrnes RW, Antholine WE, Petering DH. Oxidation-reduction reactions in Ehrlich cells treated with copper-neocuproine. Free Radic Biol Med. 1992 Nov;13(5):469-78. PubMed PMID: 1334027.
19: Vercruysse KP, Lauwers AR, Demeester JM. Kinetic investigation of the action of hyaluronidase on hyaluronan using the Morgan-Elson and neocuproine assays. Biochem J. 1995 Aug 15;310 ( Pt 1):55-9. PubMed PMID: 7646472; PubMed Central PMCID: PMC1135853.
20: Applebaum YJ, Kuvin J, Borman JB, Uretzky G, Chevion M. The protective role of neocuproine against cardiac damage in isolated perfused rat hearts. Free Radic Biol Med. 1990;8(2):133-43. PubMed PMID: 2332193.